DE69736911D1 - Kontrazeptives Implantat für Männer - Google Patents
Kontrazeptives Implantat für MännerInfo
- Publication number
- DE69736911D1 DE69736911D1 DE69736911T DE69736911T DE69736911D1 DE 69736911 D1 DE69736911 D1 DE 69736911D1 DE 69736911 T DE69736911 T DE 69736911T DE 69736911 T DE69736911 T DE 69736911T DE 69736911 D1 DE69736911 D1 DE 69736911D1
- Authority
- DE
- Germany
- Prior art keywords
- men
- implant
- androgen
- vinyl acetate
- well
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US606063 | 1996-02-23 | ||
US08/606,063 US5733565A (en) | 1996-02-23 | 1996-02-23 | Male contraceptive implant |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69736911D1 true DE69736911D1 (de) | 2006-12-14 |
DE69736911T2 DE69736911T2 (de) | 2007-06-14 |
Family
ID=24426375
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69732176T Expired - Lifetime DE69732176T2 (de) | 1996-02-23 | 1997-02-21 | Kontrazeptives implantat für männer |
DE69736911T Expired - Lifetime DE69736911T2 (de) | 1996-02-23 | 1997-02-21 | Kontrazeptives Implantat für Männer |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69732176T Expired - Lifetime DE69732176T2 (de) | 1996-02-23 | 1997-02-21 | Kontrazeptives implantat für männer |
Country Status (12)
Country | Link |
---|---|
US (1) | US5733565A (de) |
EP (2) | EP1488784B1 (de) |
JP (1) | JP2000505419A (de) |
AT (2) | ATE286370T1 (de) |
AU (1) | AU1969697A (de) |
BR (1) | BR9707637A (de) |
CA (1) | CA2243274C (de) |
DE (2) | DE69732176T2 (de) |
DK (2) | DK0881891T3 (de) |
ES (2) | ES2274367T3 (de) |
PT (2) | PT1488784E (de) |
WO (1) | WO1997030656A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306426B1 (en) | 1997-08-11 | 2001-10-23 | Allergan Sales, Inc. | Implant device with a retinoid for improved biocompatibility |
US6767902B2 (en) | 1997-09-17 | 2004-07-27 | The Population Council, Inc. | Androgen as a male contraceptive and non-contraceptive androgen replacement |
US20020012694A1 (en) * | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
US5952319A (en) | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
US6117441A (en) * | 1998-07-02 | 2000-09-12 | The Population Council, Inc. | Silicone core long term androgen delivery implant |
NZ331201A (en) * | 1998-07-30 | 2001-02-23 | Bomac Lab Ltd | Slow release implants comprising an insoluble polymeric material in the form of a porous network containing vitamin B12 dispersed within |
US6117442A (en) * | 1998-11-12 | 2000-09-12 | Leiras Oy | Drug delivery device, especially for the delivery of androgens |
PT2561860T (pt) * | 2002-05-31 | 2018-05-08 | Titan Pharmaceuticals Inc | Dispositivo polimérico implantável para a libertação prolongada de buprenorfina |
FR2842421B1 (fr) * | 2002-07-16 | 2004-10-15 | Besins Int Belgique | Nouvelles compositions pharmaceutiques a base d'inhibiteurs de la 5-alpha-reductase et leurs utilisations |
WO2004016083A1 (ja) * | 2002-08-19 | 2004-02-26 | Nagoya Industrial Science Research Institute | 球脊髄性筋萎縮症の病態を再現する非ヒト動物、及び球脊髄性筋萎縮症治療剤 |
ZA200507877B (en) | 2003-03-31 | 2007-01-31 | Titan Pharmaceuticals Inc | Implantable polymeric device for sustained release of dopamine agonist |
JO2492B1 (en) | 2003-04-28 | 2009-10-05 | شيرينج ايه جي | A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients |
ZA200509063B (en) * | 2003-05-30 | 2007-03-28 | Titan Pharmaceuticals Inc | Impiantable polymeric device for sustained release of nalmefene |
US20060093639A1 (en) * | 2004-10-29 | 2006-05-04 | Starkebaum Warren L | Method and device for destroying body tissue |
JP2008543863A (ja) * | 2005-06-15 | 2008-12-04 | ハイドラ バイオサイエンシズ インコーポレイテッド | 精子の運動亢進のモジュレーター及びその利用 |
LT2547332T (lt) * | 2010-03-16 | 2018-12-10 | Titan Pharmaceuticals, Inc. | Heterogeninės implantuojamos priemonės, skirtos vaisto pristatymui |
DE102010014113A1 (de) * | 2010-04-07 | 2011-10-13 | Acino Ag | Freisetzungsverfahren für Implantate |
EP2476409A1 (de) * | 2011-01-14 | 2012-07-18 | Université Catholique De Louvain | Implantat mit einem Kern und einer den Kern umschliessenden Röhre |
WO2017027376A1 (en) | 2015-08-07 | 2017-02-16 | Massachusetts Institute Of Technology | Subcutaneous drug delivery device with manual activation and deactivation of drug release |
SG11202005949UA (en) | 2018-05-24 | 2020-07-29 | Celanese Eva Performance Polymers Corp | Implantable device for sustained release of a macromolecular drug compound |
EP3801462A4 (de) | 2018-05-24 | 2022-03-16 | Celanese EVA Performance Polymers LLC | Implantierbare vorrichtung zur verzögerten freisetzung einer makromolekularen wirkstoffverbindung |
US11344526B2 (en) | 2020-03-20 | 2022-05-31 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11338119B2 (en) | 2020-03-20 | 2022-05-24 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
US11173291B2 (en) * | 2020-03-20 | 2021-11-16 | The Regents Of The University Of California | Implantable drug delivery devices for localized drug delivery |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4052505A (en) * | 1975-05-30 | 1977-10-04 | Alza Corporation | Ocular therapeutic system manufactured from copolymer |
US4451253A (en) * | 1980-12-18 | 1984-05-29 | Harman Sherman M | Means and method for administering medicinals |
US5028430A (en) * | 1987-05-08 | 1991-07-02 | Syntex (U.S.A.) Inc. | Delivery systems for the controlled administration of LHRH analogs |
DE3879031T2 (de) * | 1987-08-08 | 1993-06-24 | Akzo Nv | Kontrazeptives implantat. |
US5035891A (en) * | 1987-10-05 | 1991-07-30 | Syntex (U.S.A.) Inc. | Controlled release subcutaneous implant |
US5266325A (en) * | 1990-09-28 | 1993-11-30 | Hydro Med Science Division Of National Patent Development Corp. | Preparation of homogeneous hydrogel copolymers |
AU651654B2 (en) * | 1992-01-14 | 1994-07-28 | Endo Pharmaceuticals Solutions Inc. | Manufacture of water-swellable hydrophilic articles and drug delivery devices |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
-
1996
- 1996-02-23 US US08/606,063 patent/US5733565A/en not_active Expired - Lifetime
-
1997
- 1997-02-21 BR BR9707637A patent/BR9707637A/pt not_active Application Discontinuation
- 1997-02-21 DE DE69732176T patent/DE69732176T2/de not_active Expired - Lifetime
- 1997-02-21 EP EP04022014A patent/EP1488784B1/de not_active Expired - Lifetime
- 1997-02-21 EP EP97907788A patent/EP0881891B1/de not_active Expired - Lifetime
- 1997-02-21 AT AT97907788T patent/ATE286370T1/de active
- 1997-02-21 WO PCT/US1997/002798 patent/WO1997030656A1/en active IP Right Grant
- 1997-02-21 ES ES04022014T patent/ES2274367T3/es not_active Expired - Lifetime
- 1997-02-21 AU AU19696/97A patent/AU1969697A/en not_active Abandoned
- 1997-02-21 ES ES97907788T patent/ES2236793T3/es not_active Expired - Lifetime
- 1997-02-21 DK DK97907788T patent/DK0881891T3/da active
- 1997-02-21 DK DK04022014T patent/DK1488784T3/da active
- 1997-02-21 DE DE69736911T patent/DE69736911T2/de not_active Expired - Lifetime
- 1997-02-21 PT PT04022014T patent/PT1488784E/pt unknown
- 1997-02-21 PT PT97907788T patent/PT881891E/pt unknown
- 1997-02-21 JP JP9527166A patent/JP2000505419A/ja active Pending
- 1997-02-21 CA CA002243274A patent/CA2243274C/en not_active Expired - Fee Related
- 1997-02-21 AT AT04022014T patent/ATE344018T1/de active
Also Published As
Publication number | Publication date |
---|---|
WO1997030656A1 (en) | 1997-08-28 |
DE69736911T2 (de) | 2007-06-14 |
ATE286370T1 (de) | 2005-01-15 |
DK0881891T3 (da) | 2005-05-23 |
EP1488784B1 (de) | 2006-11-02 |
DK1488784T3 (da) | 2007-03-05 |
PT881891E (pt) | 2005-04-29 |
EP0881891A4 (de) | 2000-02-02 |
CA2243274C (en) | 2003-07-22 |
EP1488784A1 (de) | 2004-12-22 |
ES2236793T3 (es) | 2005-07-16 |
BR9707637A (pt) | 1999-07-27 |
AU1969697A (en) | 1997-09-10 |
ATE344018T1 (de) | 2006-11-15 |
DE69732176T2 (de) | 2006-05-11 |
JP2000505419A (ja) | 2000-05-09 |
DE69732176D1 (de) | 2005-02-10 |
ES2274367T3 (es) | 2007-05-16 |
US5733565A (en) | 1998-03-31 |
PT1488784E (pt) | 2006-12-29 |
EP0881891B1 (de) | 2005-01-05 |
CA2243274A1 (en) | 1997-08-28 |
EP0881891A1 (de) | 1998-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE286370T1 (de) | Kontrazeptives implantat für männer | |
BR0010869A (pt) | Método para administrar um corticosteróide a um segmento posterior de um olho e dispositivo de liberação sustentada implantável | |
AU1369297A (en) | Medical implant | |
DE68928897D1 (de) | Verfahren und system zur empfängnisverhütung | |
HK1035335A1 (en) | Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents p romoting the healing of wounds, to the upper respiratory tract and/or the ear | |
AU6554186A (en) | Intraintestinal bypass graft | |
IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
LT96133A (en) | Remedy for treatment of ovarian estrogen dependent conditions | |
NZ511216A (en) | Drug delivery device having a membrane composed of a siloxane based elastomer having 3,3,3-trifluoropropyl groups for the delivery of progestins and estrogens | |
IL133762A0 (en) | Transdermal therapeutic system (tts) for the administration of levonorgestral | |
CA2276587A1 (en) | Silicone core long term androgen delivery implant | |
SG47451A1 (en) | Implantable therapy system | |
GB9905663D0 (en) | Iodine preparation composition | |
CA2272732A1 (en) | Hemorrhoidal treatment composition | |
EP0365613A4 (en) | Combination of tobramycin and steroids for topical ophthalmic use | |
AU3401093A (en) | Therapeutic agent for threatened abortion | |
HUP0202741A2 (hu) | Méhen kívüli méhnyálkahártya-növekedés, krónikus medencefájdalom és petevezeték-elzáródás gyógyászati kezelésére alkalmas gyógyszerkészítmény és eljárás az előállítására | |
WO2000021511A3 (en) | Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis | |
DK561989A (da) | Fokalt ophthalmisk praeparat som indeholder en kombination af tobramycin og steroider | |
YOSHIMASU et al. | Obturator for a patient after the complete resection of the soft palate | |
UA30149A (uk) | Спосіб хірургічного лікування багаторазово рецидивуючих пахових герній | |
BG100702A (en) | Device and method for the antagonization of the toxic effect of lidocaine on the central and the vegitative nervous system | |
TH55261B (th) | การใช้ไบโอเจนิคอีสโตรเจนซัลฟาเมทในการรักษาการทดแทนฮอร์โมน | |
MX9604426A (es) | Reduccion de irritacion de la piel durante el surtido por electrotransporte. | |
UA22223A (uk) | Спосіб лікуваhhя захворюваhь оргаhа зору |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |